Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02243787
What this trial is testing

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Covagen 24
Large-scale testing (Phase 3)Study completedNCT06049810
What this trial is testing

IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 566
Large-scale testing (Phase 3)Study completedNCT01008995
What this trial is testing

The Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 322
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Early research (Phase 1)Looking for participantsNCT07024602
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Ascletis Pharma (China) Co., Limited 94
Large-scale testing (Phase 3)Study completedNCT03721172
What this trial is testing

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Who this might be right for
Psoriasis
Amgen 595
Testing effectiveness (Phase 2)Study completedNCT02173301
What this trial is testing

Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 200
Post-approval studies (Phase 4)Study completedNCT00312026
What this trial is testing

Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

Who this might be right for
Psoriasis
Genentech, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT03832738
What this trial is testing

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 152
Large-scale testing (Phase 3)Study completedNCT01406938
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 967
Testing effectiveness (Phase 2)Study completedNCT04664153
What this trial is testing

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 104
Large-scale testing (Phase 3)Study completedNCT01597245
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,224
Not applicableStudy completedNCT05344482
What this trial is testing

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 277
Testing effectiveness (Phase 2)Study completedNCT01837420
What this trial is testing

Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

Who this might be right for
Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 194
Testing effectiveness (Phase 2)Looking for participantsNCT06592274
What this trial is testing

HB0017 in Psoriasis Patients

Who this might be right for
Psoriasis (PsO)
Huabo Biopharm Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT05509361
What this trial is testing

Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 950
Testing effectiveness (Phase 2)Study completedNCT02054481
What this trial is testing

BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab

Who this might be right for
Psoriasis
Boehringer Ingelheim 166
Large-scale testing (Phase 3)Study completedNCT03168256
What this trial is testing

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 528
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Large-scale testing (Phase 3)UnknownNCT04839016
What this trial is testing

Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 660
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation